COMP <GO>
BALY vs HCMA // DIVIDEND YIELD & FCF PAYOUT SAFETY
Bally's Corporation (NYSE) VS. HCM III Acquisition Corp. Class A Ordinary Share (NASDAQ) • 15-METRIC TALLY: BALY 1
— HCMA 1
■ METRIC PARITY
LAST: $13.50 (+0.22%) • MKT CAP: $681.3M
dividend-safety
0.00%
LAST: $10.32 (0.00%) • MKT CAP: $400.5M
dividend-safety
0.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BALY VS. HCMA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BALY | HCMA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -4.70% | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -11.40% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -28.80% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -0.60% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | — | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.2 | 63.5 | -8.27 | HCMA | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $681.3M | $400.5M | $280.8M | BALY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BALY REV | HCMA REV | BALY GROSS % | HCMA GROSS % | BALY FCF | HCMA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.44B | $0 | — | — | -$178.9M | — |
| FY 2024 | $2.45B | — | — | — | -$85.8M | — |
| FY 2023 | $2.45B | — | — | — | $188.6M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BALY // BETA —
HCMA // BETA —